Adriamycin-induced heart failure: mechanism and modulation.
about
Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathyPegylated liposomal doxorubicin for multiple myelomaRoles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceAttenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division/mitophagy inhibitorNotch-1 mediated cardiac protection following embryonic and induced pluripotent stem cell transplantation in doxorubicin-induced heart failureBnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signalingAn integrated microfluidic array system for evaluating toxicity and teratogenicity of drugs on embryonic zebrafish developmental dynamics.Defective one- or two-electron reduction of the anticancer anthracycline epirubicin in human heart. Relative importance of vesicular sequestration and impaired efficiency of electron addition.Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.A mouse model for juvenile doxorubicin-induced cardiac dysfunctionAngiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats.Effects of doxorubicin on cardiac muscle subsarcolemmal and intermyofibrillar mitochondria.Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted miceOverexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in miceNAD(P)H:quinone oxidoreductase 1 is induced by progesterone in cardiomyocytes.Inhibition of apoptosis by progesterone in cardiomyocytes.Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect.Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction.Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance.Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancerShort-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72.Profiling of skeletal muscle Ankrd2 protein in human cardiac tissue and neonatal rat cardiomyocytes.Redox-proteomic analysis of doxorubicin-induced altered thiol activity in cardiomyocytes.Increasing the rate of heating: a potential therapeutic approach for achieving synergistic tumour killing in combined hyperthermia and chemotherapy.ZAK is required for doxorubicin, a novel ribotoxic stressor, to induce SAPK activation and apoptosis in HaCaT cells.Anthracycline cardiotoxicity: prevalence, pathogenesis and treatmentExercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle.Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor.Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome.Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouseBaicalein protects against doxorubicin-induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activation.Gαq protein carboxyl terminus imitation polypeptide GCIP-27 improves cardiac function in chronic heart failure rats.Trastuzumab-induced cardiac dysfunction: A 'dual-hit'Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice.Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer, directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-cancer agents.A Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats.Skeletal Muscle for Endomyocardial Biopsy: Comparable Stress Response in Doxorubicin Cardio-myopathy.Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment.Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathione.Induction of antioxidant and detoxification response by oxidants in cardiomyocytes: evidence from gene expression profiling and activation of Nrf2 transcription factor
P2860
Q21134606-2A23D80B-0D62-4A58-B7FB-FF5D5CE77980Q24235186-F6724F68-5CB9-4D69-BFA7-F69750A8C8EAQ24645668-C78E03A0-5094-4B70-92C3-5990916B108BQ28534483-6D5F6CAD-60BA-43DE-B8A9-9C8ACEC2BC80Q28540253-83CFB8DC-7C04-4C1A-AE4B-031AC803D964Q28580570-348014F0-6DC6-4693-96AA-64C5E397AD39Q30502910-E19D42AB-C166-48BF-B4C3-BD8434FE872FQ33232092-B519F68E-A2F4-4FAE-9511-6D2DC28C20C8Q33562971-453DF0AD-985B-40E7-AA3A-60692E2D7239Q33572418-1FCF58DB-2F94-4E27-86A9-AEEB08B9A16EQ33648557-70D9DB84-65AE-46A2-A4BE-7D66026EA9E9Q33649513-D1011CCF-3F2E-4580-AD90-45FF9872FC0CQ33727633-848F5B17-61C4-49AA-AF5A-F37999863F4DQ33954703-B3717D48-CE1B-49BE-B348-E67632B4C860Q34025654-092DB52F-A8C3-4D07-B5D9-A54E0F5FCE2AQ34047552-6B48E3A7-6091-4361-B3FF-0A078C0E4939Q34128868-43EBC332-0629-4D7C-A277-CEB9E5463ED5Q34241307-F44EE8FF-43DB-4C6A-A59B-269CC3BAD70EQ34258440-2293F0AE-DBAA-425C-B6DB-DC004A6422DBQ34292101-EAFD0D58-95A8-44E6-9D55-D98616982608Q34357604-E44B7BBF-8514-4D92-9E2D-F1ED9AAA8DE6Q34458052-054330B0-D9BC-4CBC-9A2C-ED39630BF753Q34557656-611E02E9-E372-4A50-B2D1-87AD0BBEC143Q34563822-EF154DB7-9BE2-43C3-B38F-849B0DF9BF35Q34581761-36B8FF0A-F86E-491C-B527-DEBD4C0FE1A0Q34639876-BE26A0C7-E08E-4C4C-BDDE-E1F0F6FDD7C3Q34785065-4147C5C3-CFDE-4EC2-9DF8-89DAEE3FA68BQ34793299-6FD46DC7-A57E-416B-A7DF-AF10B294D5B9Q35124414-D6520BF2-6AF5-47C0-A69E-876B4FE22EBBQ35163535-28BDA71C-F6A0-46E0-AB4E-10EA9F809D24Q35228139-E78EAAE3-5760-45B3-A9C1-62DBA1C37835Q35231792-EB579431-84B6-42AF-A5CE-0A16E3612B47Q35532125-441BDEF9-9E31-489C-B167-030541AAE620Q35543525-E42AF5BD-49C0-4FD9-9B8C-9B5CD834822EQ35551906-DCD45FAF-2694-4A76-83FB-22531D22827BQ35553674-6F386059-8E08-43DC-B46F-DE9FBCB494B2Q35603880-248C969B-0A47-456D-B24F-2FF00F548E93Q35609201-47FAFDC5-EDE2-46CE-927F-12E89419A57AQ35671428-30C8FEC4-3B62-4CE8-B1C4-2BCD42177178Q35757988-D620DCC6-6CC9-4D9B-830F-B1B0ADFE1556
P2860
Adriamycin-induced heart failure: mechanism and modulation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Adriamycin-induced heart failure: mechanism and modulation.
@ast
Adriamycin-induced heart failure: mechanism and modulation.
@en
type
label
Adriamycin-induced heart failure: mechanism and modulation.
@ast
Adriamycin-induced heart failure: mechanism and modulation.
@en
prefLabel
Adriamycin-induced heart failure: mechanism and modulation.
@ast
Adriamycin-induced heart failure: mechanism and modulation.
@en
P2093
P356
P1476
Adriamycin-induced heart failure: mechanism and modulation.
@en
P2093
P2888
P356
10.1023/A:1007094214460
P577
2000-04-01T00:00:00Z
P6179
1022163922